- 
                                            Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoproteinRadić, L., Offersgaard, A., Kadavá, T., Zon, I., Capella-Pujol, J., Mulder, F., Koekkoek, S., Spek, V., Chumbe, A., Bukh, J., van Gils, M. J., Sanders, R. W., Yin, V. C., Heck, A. J. R., Gottwein, J. M., Sliepen, K. & Schinkel, J., 15 Apr 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 15, e2420402122.Research output: Contribution to journal › Article › Academic › peer-review 
- 
                                            Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domainGuerra, D., Radić, L., Brinkkemper, M., Poniman, M., van der Maas, L., Torres, J. L., Ward, A. B., Sliepen, K., Schinkel, J., Sanders, R. W., van Gils, M. J. & Beaumont, T., 2024, In: Human vaccines & immunotherapeutics. 20, 1, 2388344.Research output: Contribution to journal › Article › Academic › peer-review 
- 
                                            Signatures of VH 1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteinsCapella-Pujol, J., de Gast, M., Radić, L., Zon, I., Chumbe, A., Koekkoek, S., Olijhoek, W., Schinkel, J., van Gils, M. J., Sanders, R. W. & Sliepen, K., 1 Dec 2023, In: Nature communications. 14, 1, 4036.Research output: Contribution to journal › Article › Academic › peer-review 
- All publications